References
- Black S E. Focal cortical atrophy syndromes. Brain and Cognition 1996; 31: 188–229
- Swartz R H, Black S E, St George-Hyslop P H. Apolipoprotein E and Alzheimer's Disease: a genetic, molecular and neuroimaging review. Can J Neurol Sci 1999; 26: 77–88
- Katzman R, Jackson E J. Alzheimer Disease basic and clinical advances. J Am Geriatr Soc 1991; 39: 516–525
- Selkoe D J. Alzheimer's disease: genotypes, pheno-types and treatments. Science 1995; 275: 630–631
- Sisodia S, Gallagher M. A role for the β-amyloid precursor protein in memory?. Proc Natl Acad Sci USA 1998; 95: 12074–12076
- Jarret J T, Berger E P, Lansbury P T, Jr. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's Disease. Biochemistry 1993; 32: 4693–4697
- Schonejch C. Reactive oxygen species and biological aging: a mechanistic approach. Exp Geront 1999; 34: 19–34
- Esposito L, Melov S, Panov A, Cottrel B A, Wallace D. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 1999; 96: 4820–4825
- Smith M, Sayre L, Perry G. Is Alzheimer's a disease of oxidative stress?. Alzheimer's Dis Rev 1996; 1: 63–67
- Volicer L, Crino P B. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol Aging 1990; 11: 567–571
- Hensley K, Carney J M, Mattson M P, Aksenova M, Harris M, Wu J F, Floyd R A, Butterfield D A. A model for βamyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 1994; 91: 3270–3274
- Blass J P, Gibson G E. Oxidative abnormalities in Alzheimer's disease. Rev Neurol (Paris) 1991; 147: 513–525
- Balazs L, Leon M. Evidence for an oxidative challenge in the Alzheimer's brain. Neurochem Res 1994; 19: 1131–1137
- Behl C, Davis J B, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Biochem Biophys Res Commun 1994; 186: 944–950
- Galeazzi L, Ronchi P, Franceschi C, Giunta S. In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formation. Amyloid: Int J Exp Clin Invest 1999; 6: 7–13
- Markesbery W R, Carney J M. Oxidative alterations in Alzheimer's disease. Brain Pathol. 1999; 9: 133–146
- Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-calyzed oxidation. J Biol Chem 1992; 267: 18210–18217
- Cohen G, Yakushin S, DembiecCohen D. ÊOPro-tein-Ldopa as an index of hydroxyl radical attack on protein tyrosine. Anal Biochem 1998; 263: 232–239
- Castellani R J, Smith M A, Nunomura A, Harris P LR, Perry G. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?. Free Radical Biol Med 1999; 11/12: 1508–1512
- Guptasarma P, Balasubramanian D, Matsugo S, Saito I. Hydroxyl radical mediated damage to proteins, with special reference to the crystallins. Biochemistry 1992; 31: 4296–4303
- Stadtman E R, Berlett B S. Fenton chemistry: amino acid oxidation. J Biol Chem 1991; 266: 17201–17211
- Nunomura A, Perry G, Pappolla M A, Wade R, Hirai K, Chiba S, Smith M A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999; 19: 1959–1964